HOME / PUBLICATIONS /

Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy.

Citation:

Zuidmeer-Jongejan L, Huber H, Swoboda I, Rigby N, SA V, Jensen BM, Quaak S, JH A, Blom L, Asturias J, et al. Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy. Int Arch Allergy Immunol. . 2015;166(1):41-51.